Measurement of the Energy Metabolism of Peritoneal Dialysis Patients
NCT ID: NCT03347305
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2016-08-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between the Change of Resting Energy Expenditure and Nutritional Status .
NCT03511950
Novel Equation for Estimating Resting Energy Expenditure in Dialysis Patients
NCT04947839
Effect of Intradialytic Parenteral Nutrition on Morbidity and Mortality of Malnourished Hemodialysis Patients
NCT00314834
Evaluation of Dexterity in Prevalent Peritoneal Dialysis Patients
NCT03900819
Diurnal Variation of Uremic Solutes in Peritoneal Dialysis
NCT01093456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients Group DPA
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber
automated DP
Energy expenditure measurement
Healthy Volunteers
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber
Calorimetric chamber
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
automated DP
Energy expenditure measurement
Calorimetric chamber
The main objective is to compare DE and its variations according to the conditions (rest, sleep, meals, physical activity) in patients treated with automated DP compared to controls, in a calorimetric chamber
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male patients
* Aged 18 to 70 years
* With end-stage renal disease
* Treated by automatic peritoneal
* Social security cover
* Without acute events in the 3 months prior to inclusion
* PCR \< 30 mg/L
* Written informed consent
* Baecke activity score from 5 to 10
Healthy Volunteers
* Male patients
* Aged 18 to 70 years
* Patients matched by lean body mass (± 2 kgs) and age (± 5 years)
* Having a glomerular filtration rate estimated with the formula CKD-EPI creatinine \> 60 mL / min / 1.73 m 2
* PCR \< 3 mg/L
* Social security cover
* Written informed consent
* Baecke activity score from 5 to 10
Exclusion Criteria
* Type 1 or 2 diabetes requiring a antidiabetic treatment
* Decompensated heart failure
* Smoking more than 5 cigarettes a day
* Alcoholic patients, drinking more than 3 glass of alcohol a day
* Patient Corticotherapy in progress
* Patient with evolutive acute pathology
* Person who has participated in another study within the last 30 days or is in period of exclusion on the National File of Healthy Volunteers
18 Years
70 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pôle Santé République
OTHER
Service de Néphrologie et Hémodialyse
UNKNOWN
Jacques Lacarin Hospital Center
OTHER
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien ANIORT
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00035-44
Identifier Type: OTHER
Identifier Source: secondary_id
CHU-364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.